Pancreatic Cancer Research

ResearcherSapporo Hokuyu HospitalNo recent work listed

Masahiro Ogasawara

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7919-7146; OpenAlex author ID A5004999383. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: none · 2021: 2 papers

Papers 3

  1. Baseline immunity predicts prognosis of pancreatic cancer patients treated with WT1 and/or MUC1 peptide-loaded dendritic cell vaccination and a standard chemot… Last author DOI 10.1080/21645515.2021.2003645↗
  2. Dendritic cell vaccination combined with a conventional chemotherapy for patients with relapsed or advanced pancreatic ductal adenocarcinoma: a single-center p… Co-author DOI 10.1111/1744-9987.13659↗
  3. Prognostic factors related to add-on dendritic cell vaccines on patients with inoperable pancreatic cancer receiving chemotherapy: a multicenter analysis. Co-author DOI 10.1007/s00262-014-1554-7↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Shuichi Ota · 2 shared papers, 2021 · strength 0.38
  2. Masato Okamoto · 1 shared paper, 2014 · strength 0.04
  3. Yoshikazu Yonemitsu · 1 shared paper, 2014 · strength 0.04
  4. Shigetaka Shimodaira · 1 shared paper, 2014 · strength 0.04
  5. Yuta Shibamoto · 1 shared paper, 2014 · strength 0.04
  6. Kazuhiro Nagai · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.